Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03772717 · ClinicalTrials.gov registry record · NA
Non-invasive Vagus Nerve Stimulation (nVNS) in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
A NA study, sponsored by Emory University.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03772717 is a NA study that was terminated before completion, run by Emory University. The registered enrollment target is 2 participants.
The verdict
NCT03772717, a NA study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
Participants will be requested to deliver non-invasive vagus nerve stimulation (nVNS) two times per day, at least five days per week. Participants will be followed for two years with nVNS as an adjunctive therapy to the standard of care therapy for chronic inflammatory demyelinating polyneuropathy (CIDP).
Interventions
- OTHER Standard of care treatment
- DEVICE Non-invasive vagus nerve stimulation (nVNS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2022-02-22 |
| Est. Completion | 2022-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03772717
The ClinicalTrials.gov registry entry for NCT03772717 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of care treatment is the first listed.
NCT03772717 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03772717 about?
NCT03772717 is a clinical study titled "Non-invasive Vagus Nerve Stimulation (nVNS) in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)". Participants will be requested to deliver non-invasive vagus nerve stimulation (nVNS) two times per day, at least five days per week. Participants will be followed for two years with nVNS as an adjunctive therapy to the standard of care therapy for chronic inflammatory demyelinating polyneuropathy (...
What is the current status of trial NCT03772717?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2022-02-22. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT03772717?
The interventions under investigation include: Standard of care treatment (OTHER), Non-invasive vagus nerve stimulation (nVNS) (DEVICE).
Who is sponsoring clinical trial NCT03772717?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.